Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For more than 20 years, TCT has been the center of new cutting-edge educational content. TCT showcases the latest advances in current therapies and clinical research and our long-standing commitment to life-saving innovation to translate into improved patient care.
TCT provides the latest evidence-based data presented by leading physicians, nurses and scientists that will affect the practice of interventional cardiology and endovascular medicine, current and emerging techniques and technologies with practical applications, and unparalleled diversity of live-case presentations from universities and medical centers around the world. In the field of interventional cardiology, only TCT combines late breaking science and practical learning that physicians need to improve patient outcomes.
By the end of the symposium, participants should be able to:
· Apply the results from important clinical trials and evidence-based medicine to guide management of patients with atherosclerosis and structural heart disease
· Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
· Integrate advances in diagnostic evaluation and therapeutics to patients with carotid and peripheral arterial disease
· Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
· Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease
Visit: http://www.tctconference.com/
